Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Adaptimmune Therapeutics PLC | Chief Scientific Officer | Option to purchase Ordinary Shares | 565K | Jan 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADAP | Adaptimmune Therapeutics PLC | Jan 15, 2024 | 2 | $0 | 4 | Jan 17, 2024 | Chief Scientific Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 17, 2023 | 3 | $0 | 4 | Jan 17, 2023 | Chief Scientific Officer |
ADAP | Adaptimmune Therapeutics PLC | May 4, 2022 | 2 | $0 | 4 | May 4, 2022 | Chief Scientific Officer |
ADAP | Adaptimmune Therapeutics PLC | May 4, 2022 | 0 | $0 | 3 | May 4, 2022 | Chief Scientific Officer |